T1	Outcomes 171 186	graft survival.
T2	Outcomes 369 390	graft survival rates.
T3	Outcomes 531 576	both cytotoxic and anti-idiotypic antibodies.
T4	Outcomes 726 745	Anti-HLA antibodies
T5	Outcomes 838 870	Anti-idiotypic antibody activity
T6	Outcomes 1019 1045	anti-HLA antibody response
T7	Outcomes 1050 1084	promote an anti-idiotypic response
